Kendall Keith J
Insider CIK 1406834 · FEMY Director · AQST CEO and President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FEMY FEMASYS INC | A Award deriv | 2023-06-14 | 2023-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-03-10 | 2022-03-14 | 375,000 | — | $0 | 375,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | G Gift | 2021-08-26 | 2021-08-27 | 1,000 | — | $0 | 636,149 | SEC↗ |
| AQST Aquestive Therapeutics, In | G Gift | 2021-08-26 | 2021-08-27 | 1,000 | — | $0 | 1,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2021-03-11 | 2021-03-15 | 250,000 | — | $0 | 250,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | G Gift | 2020-12-30 | 2021-01-04 | 1,000 | — | $0 | 1,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | G Gift | 2020-12-30 | 2021-01-04 | 1,000 | — | $0 | 637,149 | SEC↗ |
| AQST Aquestive Therapeutics, In | G Gift | 2020-12-30 | 2021-01-04 | 1,000 | — | $0 | 1,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | G Gift | 2020-12-30 | 2021-01-04 | 1,000 | — | $0 | 638,149 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-06-30 | 2020-07-02 | 333 | — | $0 | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-06-30 | 2020-07-02 | 333 | — | $0 | 639,297 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-06-30 | 2020-07-02 | 148 | $4.86 | $719 | 639,149 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2020-06-04 | 2020-06-05 | 50,000 | $5.11 | $255.5K | 638,964 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-05-31 | 2020-06-02 | 14,572 | — | $0 | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-05-31 | 2020-06-02 | 6,492 | $4.87 | $31.6K | 688,964 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-05-31 | 2020-06-02 | 14,572 | — | $0 | 695,456 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-03-31 | 2020-04-02 | 329 | — | $0 | 333 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-03-31 | 2020-04-02 | 99 | $2.19 | $217 | 680,884 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-03-31 | 2020-04-02 | 329 | — | $0 | 680,983 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-18 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2020-02-29 | 2020-03-03 | 14,572 | — | $0 | 14,572 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2020-02-29 | 2020-03-03 | 4,729 | $3.73 | $17.6K | 680,654 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2020-02-29 | 2020-03-03 | 14,572 | — | $0 | 685,383 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-12-31 | 2020-01-02 | 329 | — | $0 | 662 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-12-31 | 2020-01-02 | 329 | $5.82 | $1.9K | 662,656 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-12-31 | 2020-01-02 | 329 | — | $0 | 662,985 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-12-31 | 2020-02-26 | 149 | $5.82 | $867 | 670,811 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-11-30 | 2020-02-26 | 6,597 | $7.79 | $51.4K | 670,631 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-11-30 | 2019-12-02 | 14,572 | — | $0 | 29,144 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-11-30 | 2019-12-02 | 14,572 | $7.79 | $113.5K | 662,656 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-11-30 | 2019-12-02 | 14,572 | — | $0 | 677,228 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-09-30 | 2019-10-02 | 329 | — | $0 | 991 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-09-30 | 2019-10-02 | 150 | $3.18 | $477 | 662,656 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-09-30 | 2019-10-02 | 329 | — | $0 | 662,806 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-08-31 | 2019-09-03 | 14,572 | — | $0 | 43,716 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-08-31 | 2019-09-03 | 14,572 | — | $0 | 669,153 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-08-31 | 2019-09-03 | 6,676 | $3.80 | $25.4K | 662,477 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-14 | 2019-08-20 | 1,000 | $3.70 | $3.7K | 653,581 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-14 | 2019-08-20 | 1,000 | $3.65 | $3.6K | 654,581 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-13 | 2019-08-20 | 1,000 | $4.05 | $4.0K | 652,581 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-09 | 2019-08-20 | 2,000 | $4.00 | $8.0K | 651,581 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-09 | 2019-08-20 | 2,000 | $3.84 | $7.7K | 648,581 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-09 | 2019-08-20 | 1,000 | $3.93 | $3.9K | 649,581 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-06-30 | 2019-07-02 | 329 | — | $0 | 1,320 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-06-30 | 2019-07-02 | 154 | $4.20 | $647 | 646,581 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-06-30 | 2019-07-02 | 329 | — | $0 | 646,735 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-05-31 | 2019-06-03 | 14,572 | — | $0 | 58,288 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-05-31 | 2019-06-03 | 14,572 | — | $0 | 653,186 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-05-31 | 2019-06-03 | 6,780 | $3.72 | $25.2K | 646,406 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-03-31 | 2019-04-01 | 329 | — | $0 | 1,649 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-03-31 | 2019-04-01 | 263 | $6.91 | $1.8K | 638,614 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-03-31 | 2019-04-01 | 329 | — | $0 | 638,877 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2019-02-28 | 2019-03-01 | 14,572 | — | $0 | 72,860 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-02-28 | 2019-03-04 | 325,000 | — | $0 | 325,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2019-02-28 | 2019-03-01 | 14,572 | — | $0 | 643,273 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2019-02-28 | 2019-03-01 | 4,725 | $8.05 | $38.0K | 638,548 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-12-31 | 2019-01-03 | 329 | — | $0 | 1,978 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-12-31 | 2019-01-03 | 329 | — | $0 | 628,863 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-12-31 | 2019-01-03 | 162 | $6.30 | $1.0K | 628,701 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-11-30 | 2018-12-04 | 14,572 | — | $0 | 87,432 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-11-30 | 2018-12-04 | 7,177 | $8.59 | $61.7K | 628,534 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-11-30 | 2018-12-04 | 14,572 | — | $0 | 635,711 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-11-27 | 2018-11-28 | 1,000 | $9.87 | $9.9K | 621,139 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-11-23 | 2018-11-26 | 1,950 | $9.90 | $19.3K | 620,139 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-11-21 | 2018-11-26 | 6,000 | $10.17 | $61.0K | 618,189 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-09-30 | 2018-10-02 | 329 | — | $0 | 2,307 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-09-30 | 2018-10-02 | 162 | $17.51 | $2.8K | 1,008,229 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-09-30 | 2018-10-02 | 329 | — | $0 | 1,008,391 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise deriv | 2018-08-31 | 2018-09-05 | 14,572 | — | $0 | 102,004 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2018-08-31 | 2018-09-05 | 6,510 | $18.01 | $117.2K | 1,008,062 | SEC↗ |
| AQST Aquestive Therapeutics, In | M Exercise | 2018-08-31 | 2018-09-05 | 14,572 | — | $0 | 1,014,572 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-08-15 | 2018-08-17 | 28,043 | — | $0 | 28,043 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-08-15 | 2018-08-17 | 2,636 | — | $0 | 2,636 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 240,165 | — | $0 | 240,165 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 116,576 | — | $0 | 116,576 | SEC↗ |